Colistin Heteroresistance in <i>Klebsiella Pneumoniae</i> Isolates and Diverse Mutations of PmrAB and PhoPQ in Resistant Subpopulations

Heteroresistance may pose a threat to the prognosis of patients following colistin treatment. We investigated colistin heteroresistance in <i>Klebsiella pneumoniae</i> isolates from South Korea. Among 252 <i>K. pneumoniae</i> blood isolates, 231 were susceptible to polymyxins...

Full description

Bibliographic Details
Main Authors: Hae Suk Cheong, So Yeon Kim, Yu Mi Wi, Kyong Ran Peck, Kwan Soo Ko
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/8/9/1444
Description
Summary:Heteroresistance may pose a threat to the prognosis of patients following colistin treatment. We investigated colistin heteroresistance in <i>Klebsiella pneumoniae</i> isolates from South Korea. Among 252 <i>K. pneumoniae</i> blood isolates, 231 were susceptible to polymyxins. Heteroresistance to colistin was determined using population analysis profiles, disk diffusion assays, and E-test strip tests for the susceptible isolates. As a result, we identified three colistin-heteroresistant <i>K. pneumoniae</i> isolates belonging to separate clones (ST11, ST461, and ST3217) by multilocus sequence typing analysis. Two colistin-resistant subpopulations were selected from each heteroresistant isolate in either disk diffusion testing or E-testing. Two resistant subpopulations from the same isolate exhibited different amino acid substitutions in the two-component regulatory systems PmrAB and PhoPQ. An in vitro time&#8722;kill assay showed that meropenem combined with colistin had a 1&#215; minimum inhibitory concentration bactericidal effect against a multidrug-resistant, colistin-heteroresistant isolate.
ISSN:2077-0383